Lloyd Dunlap
This person does not yet have a bio.
Articles by Lloyd Dunlap
| 3 min read
OncoMed presents updated Phase 1b data for
tarextumab in small cell lung cancer
| 4 min read
No new safety or tolerability issues were identified during the blinded extension
| 3 min read
WaferGen announces key findings from collaborators Genentech, Karolinska Institutet, National Jewish Health, and MD Anderson Cancer utilizing company’s
ICELL8 Single-Cell System
| 3 min read
Topline results in Class
3 mutation patients expected Q4 2016
| 2 min read
Current HTS assays may miss chemicals that are metabolized to a more toxic form; government agencies are encouraging
solutions
| 3 min read
Spark unveils vision of having 10 clinical-stage gene
therapy programs by 2018, including one commercial and two in pivotal trials
| 4 min read
Preclinical data evaluating cone-specific promoters further validate company’s technology
| 3 min read
Fibrocell and Intrexon to
develop treatment for arthritis and related conditions through targeted, long-term therapeutic delivery
| 4 min read
XBiotech reports
additional positive data from Phase 3 European trial of Xilonix in advanced colorectal cancer
| 3 min read
Genticel to evaluate Roche HPV test in preparation for Phase 3 program of GTL001
| 3 min read
Proof-of-
concept was achieved with significant reductions in time to platelet count normalization and recurrences while on treatment with caplacizumab
| 4 min read
DDNews speaks with Anthony Mack of SCILEX Pharmaceuticals on the management of pain
